Integrated Filing — IndAS


General information about company

Scrip Code 539787
NSE Symbol HCG
MSEI Symbol NOTLISTED
ISIN INE075I01017
Name of company Healthcare Global Enterprises Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 24-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 12-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Healthcare
Start date and time of board meeting 24-May-2025   14:15:00
End date and time of board meeting 24-May-2025   19:10:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-13
Indicate Company website link for updated RPT policy of the Company www.hcgoncology.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The compnay has not defaulted in repayment of loans. The Company has not issued debt securities.



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 3243900000 12804900000
Other income 94600000 346100000
Total income 3338500000 13151000000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 787500000 3212500000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 7100000 -36000000
(d) Employee benefit expense 521100000 2205800000
(e) Finance costs 225000000 841400000
(f) Depreciation, depletion and amortisation expense 290500000 1113900000
(f) Other Expenses
1 Medical Consultancy charges 636500000 2492000000
2 Other Expenses 702700000 2777400000
Total other expenses 1339200000 5269400000
Total expenses 3170400000 12607000000
3 Total profit before exceptional items and tax 168100000 544000000
4 Exceptional items 0 -348200000
5 Total profit before tax 168100000 195800000
6 Tax expense
7 Current tax 82400000 206600000
8 Deferred tax -15900000 -46100000
9 Total tax expenses 66500000 160500000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 101600000 35300000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 101600000 35300000
17 Other comprehensive income net of taxes 3100000 3000000
18 Total Comprehensive Income for the period 104700000 38300000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1394200000 1394200000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.73 0.25
Diluted earnings (loss) per share from continuing operations 0.72 0.25
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.73 0.25
Diluted earnings (loss) per share from continuing and discontinued operations 0.72 0.25
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 9350200000
Capital work-in-progress 226100000
Investment property 0
Goodwill 901400000
Other intangible assets 128800000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 6957500000
Trade receivables, non-current 0
Loans, non-current 377700000
Other non-current financial assets 765100000
Total non-current financial assets 8100300000
Deferred tax assets (net) 538500000
Other non-current assets 388200000
Total non-current assets 19633500000
2 Current assets
Inventories 197600000
Current financial asset
Current investments 0
Trade receivables, current 2619800000
Cash and cash equivalents 1580300000
Bank balance other than cash and cash equivalents 1061100000
Loans, current 16500000
Other current financial assets 659500000
Total current financial assets 5937200000
Current tax assets (net) 0
Other current assets 269700000
Total current assets 6404500000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 26038000000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1394200000
Other equity 10519000000
Total equity attributable to owners of parent 11913200000
Non controlling interest
Total equity 11913200000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 3035700000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 4342200000
Total non-current financial liabilities 7377900000
Provisions, non-current 124000000
Deferred tax liabilities (net) 51700000
Deferred government grants, Non-current 0
Other non-current liabilities 342800000
Total non-current liabilities 7896400000
Current liabilities
Current financial liabilities
Borrowings, current 3477200000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 20900000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1500700000
Total Trade payable 1521600000
Other current financial liabilities 832800000
Total current financial liabilities 5831600000
Other current liabilities 210000000
Provisions, current 160400000
Current tax liabilities (Net) 26400000
Deferred government grants, Current 0
Total current liabilities 6228400000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 14124800000
Total equity and liabilites 26038000000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans 4000000 3900000
2 Income tax effect on above -900000 -900000
Total Amount of items that will not be reclassified to profit and loss 3100000 3000000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
1 Effective portion of gain on hedging instruments in cash flow hedge 0 0
2 Income tax effect on above 0 0
Total Amount of items that will be reclassified to profit and loss 0 0
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 3100000 3000000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 195800000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 841400000
Adjustments for decrease (increase) in inventories -28900000
Adjustments for decrease (increase) in trade receivables, current -745100000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -230900000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 198800000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 1113900000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 24200000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -1400000
Adjustments for dividend income 0
Adjustments for interest income 148800000
Adjustments for share-based payments 58800000
Adjustments for fair value losses (gains) -1600000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 368900000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 1449300000
Net cash flows from (used in) operations 1645100000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 185600000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 1459500000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 2174200000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 1327200000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 83000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -54900000
Net cash flows from (used in) investing activities -3473300000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 15600000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 991400000
Repayments of borrowings 417300000
Payments of lease liabilities 539200000
Dividends paid 0
Interest paid 466000000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -415500000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -2429300000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -2429300000
Cash and cash equivalents cash flow statement at beginning of period 1211800000
Cash and cash equivalents cash flow statement at end of period -1217500000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 B S R & Co. LLP Yes 31-Jul-2025


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Sale of goods or services 56500000 Approved 15726000 51340000 1430000 Any other NA 0 Not Applicable
2 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Purchase of goods or services 11500000 Approved 6340000 1160000 1240000 Any other NA 0 Not Applicable
3 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Corporate guarantee commission income received 0 Approved 0 0 0 Any other NA 0 Not Applicable
4 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Approved 0 0 0 Any other NA 0 Not Applicable
5 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Payments on behalf of 10820000 Approved 10820000 0 0 Any other NA 0 Not Applicable
6 HealthCare Global Enterprises Limited HCG Medi-surge Hospitals Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 12820000 Approved 12820000 49480000 60880000 Any other NA 0 Not Applicable
7 HCG Medi-Surge Hospitals Private limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 795000 Approved 795000 53000 53000 Any other NA 0 Not Applicable
8 HCG Medi-Surge Hospitals Private limited HCG Oncology LLP Subsidiary LLP Sale of fixed assets 0 Approved 0 39000 39000 Any other NA 0 Not Applicable
9 HCG Medi-Surge Hospitals Private limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 116000 Approved 116000 3000 140000 Any other NA 0 Not Applicable
10 HCG Medi-Surge Hospitals Private limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Medical Consultant fee 259000000 Approved 259000000 37670000 34622000 Any other NA 0 Not Applicable
11 HCG Medi-Surge Hospitals Private limited Astha Oncology Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0 Approved 0 0 0 Any other NA 0 Not Applicable
12 HCG Medi-Surge Hospitals Private limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0 Not Applicable 37000 270000 305000 Any other NA 0 Not Applicable
13 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Sale of goods or services 11250000 Approved 0 900000 0 Any other NA 0 Not Applicable
14 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Purchase of goods or services 10250000 Approved 5060000 200000 510000 Any other NA 0 Not Applicable
15 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Purchase of fixed assets 0 Approved 0 0 0 Any other NA 0 Not Applicable
16 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 240000 Approved 240000 0 0 Any other NA 0 Not Applicable
17 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 1210000 Approved 1210000 0 0 Any other NA 0 Not Applicable
18 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 9570000 Approved 9570000 0 0 Any other NA 0 Not Applicable
19 HealthCare Global Enterprises Limited HCG Oncology LLP Subsidiary LLP Any other transaction Payments on behalf of 440000 Approved 440000 24730000 23190000 Any other NA 0 Not Applicable
20 HCG Oncology LLP Dr. Rajiv Gopinath Bhat Partner Any other transaction Medical Service 38270000 Approved 38270000 7560000 8283000 Any other NA 0 Not Applicable
21 HCG Oncology LLP HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 250000 Approved 250000 30000 150000 Any other NA 0 Not Applicable
22 HCG Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 483000 Not Applicable 483000 9000 19000 Any other NA 0 Not Applicable
23 HealthCare Global Enterprises Limited Nagpur Cancer Hospital and Research Institute Pvt Ltd Subsidiary Company Any other transaction Revenue Share 0 Not Applicable 356820000 0 438060000 Any other NA 0 Not Applicable
24 HCG NCHRI Oncology LLP HealthCare Global Enterprises Limited Parent Company Sale of goods or services 0 Not Applicable 107480000 0 28609000 Any other NA 0 Not Applicable
25 HCG NCHRI Oncology LLP HCG Medi-surge Hospitals Private Limited Fellow Subsidiary Sale of goods or services 0 Not Applicable 31812000 0 63905000 Any other NA 0 Not Applicable
26 HCG NCHRI Oncology LLP Suchirayu Health Care Solutions Limited Fellow Subsidiary Sale of goods or services 0 Not Applicable 13355000 0 7437000 Any other NA 0 Not Applicable
27 HCG NCHRI Oncology LLP Malnad Hospital & Institute of Oncology Private Limited Fellow Subsidiary Sale of goods or services 0 Not Applicable 449000 0 352000 Any other NA 0 Not Applicable
28 HCG NCHRI Oncology LLP BACC Healthcare Private Limited Fellow Subsidiary Sale of goods or services 0 Not Applicable 561000 0 2676000 Any other NA 0 Not Applicable
29 HCG NCHRI Oncology LLP HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Fellow Subsidiary Sale of goods or services 0 Not Applicable 12887000 0 67384000 Any other NA 0 Not Applicable
30 HCG NCHRI Oncology LLP HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Fellow Subsidiary Sale of goods or services 0 Not Applicable 0 0 140000 Any other NA 0 Not Applicable
31 HCG NCHRI Oncology LLP HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Fellow Subsidiary Sale of goods or services 0 Not Applicable 11409000 0 80350000 Any other NA 0 Not Applicable
32 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 11051000 Approved 11051000 8140000 6360000 Any other NA 0 Not Applicable
33 HealthCare Global Enterprises Limited HCG Foundation Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Other payable 0 Approved 0 100000 170000 Any other NA 0 Not Applicable
34 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 9800000 Approved 5460000 5170000 260000 Any other NA 0 Not Applicable
35 HealthCare Global Enterprises Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of fixed assets 18200000 Approved 18200000 0 0 Any other NA 0 Not Applicable
36 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0 Not Applicable 5440000 0 0 Any other NA 0 Not Applicable
37 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Interest received 0 Not Applicable 5840000 0 0 Any other NA 0 Not Applicable Loan 0.1 1 Unsecured As per the business needs
38 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0 Not Applicable 250000 0 0 Any other NA 0 Not Applicable
39 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Not Applicable 2680000 0 0 Any other NA 0 Not Applicable
40 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0 Not Applicable 18240000 0 0 Any other NA 0 Not Applicable
41 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 50390000 0 0 Any other NA 0 Not Applicable
42 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Other payable 0 Not Applicable 3870000 0 2204000 Any other NA 0 Not Applicable
43 HealthCare Global Enterprises Limited HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) Wholly - owned subsidiary LLP Loan 0 Not Applicable 0 122880000 128710000 Any other NA 0 Not Applicable Loan 0.1 1 Unsecured As per the business needs
44 HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 38000 24000 62000 Any other NA 0 Not Applicable
45 HCG Oncology Hospitals LLP (formerly, Apex HCG Oncology Hospitals LLP) HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 0 1130000 619000 Any other NA 0 Not Applicable
46 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Corporate guarantee commission income received 0 Not Applicable 1520000 0 0 Any other NA 0 Not Applicable
47 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 2660000 Not Applicable 2660000 11600000 14890000 Any other NA 0 Not Applicable
48 HealthCare Global Enterprises Limited HCG Manavata Oncology LLP Subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 0 0 0 Any other NA 0 Not Applicable
49 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0 Not Applicable 60000 20000 9000 Any other NA 0 Not Applicable
50 HCG Manavata Oncology LLP RAJNISH VASANTRAO NAGARKAR HUF Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0 Not Applicable 150000 24000 24000 Any other NA 0 Not Applicable
51 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Rent charges 45950000 Approved 45970000 7000000 0 Any other NA 0 Not Applicable
52 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Any other transaction Medical Consultant fee 72180000 Approved 51252000 22560000 22560000 Any other NA 0 Not Applicable
53 HCG Manavata Oncology LLP Dr RAJ VASANTRAO NAGARKAR Partner Sale of goods or services 0 Not Applicable 230000 0 63000 Any other NA 0 Not Applicable
54 HCG Manavata Oncology LLP VASANTRAO RUDRAPPA NAGARKAR MEDICAL FOUNDATION Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0 Not Applicable 1849000 0 0 Any other NA 0 Not Applicable
55 HCG Manavata Oncology LLP KIMS Manavata Multi Speciality Hospital Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0 Not Applicable 5113000 0 5630000 Any other NA 0 Not Applicable
56 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Sale of goods or services 55000000 Not Applicable 20080000 10350000 10690000 Any other NA 0 Not Applicable
57 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 9660000 Approved 9660000 0 0 Any other NA 0 Not Applicable
58 HealthCare Global Enterprises Limited Suchirayu Health Care Solutions Limited Subsidiary Company Any other transaction Payments on behalf of 100000 Approved 100000 40000 6470000 Any other NA 0 Not Applicable
59 Suchirayu Health Care Solutions Limited International Human Development and Upliftment Academy (Trust) Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction CSR 671000 Approved 671000 0 0 Any other NA 0 Not Applicable
60 Suchirayu Health Care Solutions Limited Noth Karnataka Sleep Center Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Revenue Share 0 Not Applicable 370000 50000 0 Any other NA 0 Not Applicable
61 Suchirayu Health Care Solutions Limited Dr Rajendra Ishwarappa Dugani Director Any other transaction Medical Consultant fee 0 Not Applicable 5209000 970000 757000 Any other NA 0 Not Applicable
62 Suchirayu Health Care Solutions Limited Dr Sadashivayya Shadaksharayya Soppimath Director Any other transaction Medical Consultant fee 0 Not Applicable 2887000 620000 310000 Any other NA 0 Not Applicable
63 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Sale of goods or services 1500000 Approved 210000 1009000 470000 Any other NA 0 Not Applicable
64 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 160000 Approved 160000 0 0 Any other NA 0 Not Applicable
65 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Payments on behalf of 6110000 Approved 6110000 8400000 4070000 Any other NA 0 Not Applicable
66 HealthCare Global Enterprises Limited Malnad Hospital & Institute of Oncology Private Limited Subsidiary Company Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0 Not Applicable 0 3000000 3000000 Any other NA 0 Not Applicable
67 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Advance 0 Not Applicable 0 9000000 7766000 Any other NA 0 Not Applicable
68 Malnad Hospital & Institute of Oncology Private Limited Sada Sarada Tumor & Research Institute Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Rent charges 0 Not Applicable 1474000 0 0 Any other NA 0 Not Applicable
69 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Security Deposit 0 Not Applicable 0 3500000 3500000 Any other NA 0 Not Applicable
70 Malnad Hospital & Institute of Oncology Private Limited Gutti Malnad Hospital LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Sale of goods or services 0 Not Applicable 0 1350000 1350000 Any other NA 0 Not Applicable
71 Malnad Hospital & Institute of Oncology Private Limited Malnad Hi-Tech Diagnostic Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0 Not Applicable 273000 1110000 1386000 Any other NA 0 Not Applicable
72 Malnad Hospital & Institute of Oncology Private Limited Malnad MRI Centre LLP Company / entity in which KMP / Relatives of KMP can exercise significant influence Purchase of goods or services 0 Not Applicable 0 23000 23000 Any other NA 0 Not Applicable
73 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Sale of goods or services 0 Not Applicable 270000 1930000 0 Any other NA 0 Not Applicable
74 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Not Applicable 190000 0 0 Any other NA 0 Not Applicable
75 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0 Not Applicable 730000 12260000 13320000 Any other NA 0 Not Applicable
76 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Payments on behalf of 0 Not Applicable 150000 0 0 Any other NA 0 Not Applicable
77 HealthCare Global Enterprises Limited BACC Healthcare Private Limited Subsidiary Company Any other transaction Other payable 0 Not Applicable 0 18860000 18860000 Any other NA 0 Not Applicable
78 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Sale of goods or services 0 Not Applicable 5400000 28250000 1710000 Any other NA 0 Not Applicable
79 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Sale of fixed assets 0 Not Applicable 1710000 30000 0 Any other NA 0 Not Applicable
80 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Finance lease income 0 Not Applicable 20480000 417560000 411930000 Any other NA 0 Not Applicable
81 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Interest received 0 Not Applicable 4750000 0 0 Any other NA 0 Not Applicable
82 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Loan 0 Not Applicable 0 100200000 104960000 Any other NA 0 Not Applicable Loan 0.1 1 Unsecured As per the business needs
83 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0 Not Applicable 860000 0 0 Any other NA 0 Not Applicable
84 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Not Applicable 570000 0 0 Any other NA 0 Not Applicable
85 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0 Not Applicable 8590000 0 0 Any other NA 0 Not Applicable
86 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 16470000 79780000 99400000 Any other NA 0 Not Applicable
87 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0 Not Applicable 0 14610000 14610000 Any other NA 0 Not Applicable
88 HealthCare Global Enterprises Limited HCG KOLKATA CANCER CARE LLP (Formerly known as HCG EKO Oncology LLP) Wholly - owned subsidiary LLP Any other transaction Allowance for doubtful trade receivables 0 Not Applicable 0 30150000 2110000 Any other NA 0 Not Applicable
89 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Sale of goods or services 0 Not Applicable 80000 13670000 13670000 Any other NA 0 Not Applicable
90 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Corporate guarantee commission income received 0 Not Applicable 500000 0 0 Any other NA 0 Not Applicable
91 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Not Applicable 260000 0 0 Any other NA 0 Not Applicable
92 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Reimbursement of capital expenditure/ revenue expenditure cross charged by the Company 0 Not Applicable 12060000 0 0 Any other NA 0 Not Applicable
93 HealthCare Global Enterprises Limited HCG RAJKOT HOSPITALS LLP (Formerly known as HCG Sun Hospitals LLP) Wholly - owned subsidiary LLP Any other transaction Payments on behalf of 0 Not Applicable 1100000 26780000 41200000 Any other NA 0 Not Applicable
94 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Loan 0 Not Applicable 0 137420000 143904000 Any other NA 0 Not Applicable Loan 0.1 1 Unsecured As per the business needs
95 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Interest received 0 Not Applicable 6480000 0 0 Any other NA 0 Not Applicable
96 HealthCare Global Enterprises Limited HCG NCHRI Oncology LLP Wholly - owned subsidiary LLP Any other transaction Interest accrued on loan/ capital contribution by subsidiaries 0 Not Applicable 0 29350000 29350000 Any other NA 0 Not Applicable
97 HealthCare Global Enterprises Limited GHA Global Healthcare Academy Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Promotion and Marketing of offline and online courses 22000000 Approved 2330000 0 0 Any other NA 0 Not Applicable
98 HealthCare Global Enterprises Limited Irelia Sports India Private Limited Company / entity in which KMP / Relatives of KMP can exercise significant influence Any other transaction Business promotion expenses 11350000 Approved 3730000 0 0 Any other NA 0 Not Applicable
99 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Any other transaction Other payable 0 Not Applicable 0 2530000 2530000 Any other NA 0 Not Applicable
100 HealthCare Global Enterprises Limited Healthcare Diwan Chand Imaging LLP Subsidiary LLP Purchase of goods or services 0 Not Applicable 0 24630000 24630000 Any other NA 0 Not Applicable
101 HealthCare Global Enterprises Limited Cancer Care Kenya Limited Wholly - owned subsidiary LLP Any other transaction Reimbursement of expense on employee stock option scheme cross charged by the Company 0 Not Applicable 150000 580000 730000 Any other NA 0 Not Applicable
102 HealthCare Global Enterprises Limited HCG (Mauritius) Private Limited Wholly - owned subsidiary LLP Investment 0 Not Applicable 0 355240000 355240000 Any other NA 0 Not Applicable
103 HealthCare Global Enterprises Limited Dr. B S Ajaikumar Whole-time director Remuneration 0 Not Applicable 30000000 19540000 37004000 Any other NA 0 Not Applicable
104 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Remuneration 0 Not Applicable 28950000 0 13030000 Any other NA 0 Not Applicable
105 HealthCare Global Enterprises Limited Meghraj Arvindrao Gore Key Managerial Personnel Any other transaction Share based payments 0 Not Applicable 6970000 0 0 Any other NA 0 Not Applicable
106 HealthCare Global Enterprises Limited Ms. Anjali Ajaikumar Key Managerial Personnel Remuneration 0 Not Applicable 7990000 2240000 3950000 Any other NA 0 Not Applicable
107 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Remuneration 0 Not Applicable 7360000 2840000 4836000 Any other NA 0 Not Applicable
108 HealthCare Global Enterprises Limited Ruby Ritolia Key Managerial Personnel Any other transaction Share based payments 0 Not Applicable 6040000 0 0 Any other NA 0 Not Applicable
109 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Remuneration 0 Not Applicable 2840000 2840000 677000 Any other NA 0 Not Applicable
110 HealthCare Global Enterprises Limited Sunu Manuel Key Managerial Personnel Any other transaction Share based payments 0 Not Applicable 240000 0 0 Any other NA 0 Not Applicable
111 HealthCare Global Enterprises Limited Rajiv Maliwal Independent Directors Any other transaction Sitting fees to Directors 0 Not Applicable 1180000 0 0 Any other NA 0 Not Applicable
112 HealthCare Global Enterprises Limited Pradip M. Kanakia Independent Directors Any other transaction Sitting fees to Directors 0 Not Applicable 1180000 0 0 Any other NA 0 Not Applicable
113 HealthCare Global Enterprises Limited Geeta Mathur Independent Directors Any other transaction Sitting fees to Directors 0 Not Applicable 1180000 0 0 Any other NA 0 Not Applicable
114 HealthCare Global Enterprises Limited Rajagopalan Raghavan Independent Directors Any other transaction Sitting fees to Directors 0 Not Applicable 1180000 0 0 Any other NA 0 Not Applicable
115 HealthCare Global Enterprises Limited Amit Soni Non-executive directors Any other transaction NA 0 Not Applicable 0 0 0 Any other NA 0 Not Applicable
116 HealthCare Global Enterprises Limited Siddharth Patel Non-executive directors Any other transaction NA 0 Not Applicable 0 0 0 Any other NA 0 Not Applicable
Total value of transaction during the reporting period 1355387000





Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt